Figure 1
From: An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
Studies included in overall analysis of EPT and risk of breast cancer: odds ratios with 95% CIs per year of use.
Figure 1 | British Journal of Cancer
From: An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
Studies included in overall analysis of EPT and risk of breast cancer: odds ratios with 95% CIs per year of use.
